Evidence map›Paper›PMID 40034807›Full record

ArticleBioactive materials2025

"Monitor-and-treat" that integrates bacterio-therapeutics and bio-optics for infected wound management.

Longbao Feng, Qing Peng, Li Miao, Chenghao Cai, Franklin R Tay, Shuqin Zhou, Ying Zhang, Zonghua Liu, Xingang Wang, Yang Jiao and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioactive materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Longbao FengKey Laboratory of Biomaterials of Guangdong Higher Education Institutes, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrie Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, PR China.
Qing PengCentral Laboratory of the Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, PR China.
Li MiaoDepartment of Stomatology, The Seventh Medical Center of PLA General Hospital, Beijing, 100700, PR China.
Chenghao CaiDepartment of Burns & Wound Care Center, The 2nd Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310009, PR China.
Franklin R TayThe Graduate School, Augusta University, Augusta, GA, 30912, USA.
Shuqin ZhouDepartment of Anesthesiology of the Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, PR China.
Ying ZhangCentral Laboratory of the Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, 518172, PR China.
Zonghua LiuKey Laboratory of Biomaterials of Guangdong Higher Education Institutes, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrie Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, PR China.
Xingang WangDepartment of Burns & Wound Care Center, The 2nd Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, 310009, PR China.
Yang JiaoDepartment of Stomatology, The Seventh Medical Center of PLA General Hospital, Beijing, 100700, PR China.
Rui GuoKey Laboratory of Biomaterials of Guangdong Higher Education Institutes, Guangdong Provincial Engineering and Technological Research Centre for Drug Carrie Development, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wound infections are one of the major threats to human health, accounting for millions of deaths annually. Real-time monitoring, accurate diagnosis, and on-demand therapy are crucial to minimizing complications and saving lives. Herein, we propose a "monitor-and-treat" strategy for infected wound management by integrating the emerging development of bacterio-therapeutics and bio-optics. The upper layer consists of gelatin methacryloyl (GelMA)-collagen III methacryloyl (Col

Indexed as

Bacterio-therapeuticsBio-opticsHydrogelInfected woundMultifunctional

Identifiers

PMID40034807
PMCPMC11872670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.